Biogen to Present at the 2017 RBC Capital Markets Global Healthcare Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Biogen
Inc. (NASDAQ: BIIB) announced today that it will present at the 2017
RBC Capital Markets Global Healthcare Conference. The webcast will be
live on Wednesday, February 22, 2017 at 3:05 p.m. EST. To access the
live webcast, please visit Biogen’s Investors section at www.biogen.com/investors.
An archived version of the webcast will be available following the
presentation.

About Biogen
Through cutting-edge science and medicine,
Biogen discovers, develops and delivers worldwide innovative therapies
for people living with serious neurological and neurodegenerative
diseases. Founded in 1978, Biogen is a pioneer in biotechnology and
today the Company has the leading portfolio of medicines to treat
multiple sclerosis, has introduced the first and only approved treatment
for spinal muscular atrophy, and is at the forefront of neurology
research for conditions including Alzheimer’s disease, Parkinson’s
disease and amyotrophic lateral sclerosis (ALS). Building on its
heritage in biologics, Biogen also manufactures and commercializes
high-quality biosimilars. For more information, please visit www.biogen.com.
Follow us on social media – Twitter,
LinkedIn,
Facebook,
YouTube.

Image may be NSFW.
Clik here to view.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170215006358/en/